Literature DB >> 535601

The intestinal absorption and excretion of 14C drotaverin in rats.

G Simon, Z Vargay, M Winter, T Szüts.   

Abstract

The absorption and biliary excretion of drotaverin/a papaverine analogue/were studied in rats. In vivo loop technique was used. The absorption of the compounds from the jejunum was found to be rapid and the activity injected into the duodenal sac to disappear only when the common bile duct was ligated. An appreciable activity was detected in the bile collected by cannulation following both i.v. (67%) or per os (31%) administration. Considerable activity was excreted with the bile even 24 hours after drug administration. A partial entero-hepatic cycle for the drotaverin metabolites is suggested.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 535601     DOI: 10.1007/BF03189429

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  3 in total

1.  Data on the metabolism of benzylisoquinoline derivatives. The metabolism of drotaverin.

Authors:  L Gyarmati; A Dávid; Z Mészáros; I Rácz; P Szentmiklósi
Journal:  Pharmazie       Date:  1975-03       Impact factor: 1.267

2.  The excretion of 3H-papaverine in the rat.

Authors:  F M Belpaire; M G Bogaert
Journal:  Biochem Pharmacol       Date:  1973-01-01       Impact factor: 5.858

3.  Absorption, distribution and elimination of drotaverine.

Authors:  K Magyar; M Lengyel; J Knoll
Journal:  Acta Physiol Acad Sci Hung       Date:  1978
  3 in total
  3 in total

1.  Pharmacokinetics and bioavailability of drotaverine in humans.

Authors:  O O Bolaji; C O Onyeji; A O Ogundaini; T A Olugbade; F A Ogunbona
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Jul-Sep       Impact factor: 2.441

2.  The fate of drotaverine-acephyllinate in rat and man. I. Absorption, distribution and excretion in the rat.

Authors:  I Szatmári; G Simon; Z Vargay; E Tóth; T Szüts
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Jan-Mar       Impact factor: 2.441

3.  The fate of drotaverine-acephyllinate in rat and man. II. Human pharmacokinetics of drotaverine-14C-acephyllinate.

Authors:  Z Vargay; T Deutsch; I Szatmári; T Szüts; P Várkonyi; S Kerpel-Fronius; S Eckhardt
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Jan-Mar       Impact factor: 2.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.